{"pmid":32452247,"title":"Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era.","text":["Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era.","J Am Heart Assoc","Mentias, Amgad","Jneid, Hani","32452247"],"journal":"J Am Heart Assoc","authors":["Mentias, Amgad","Jneid, Hani"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452247","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1161/JAHA.120.017121","keywords":["covid-19","aortic stenosis","transcatheter aortic valve replacement"],"topics":["Prevention"],"weight":1,"_version_":1667881798521061377,"score":9.490897,"similar":[{"pmid":32301976,"pmcid":"PMC7184510","title":"Management of elective aortic valve replacement over the long term in the era of COVID-19.","text":["Management of elective aortic valve replacement over the long term in the era of COVID-19.","Eur J Cardiothorac Surg","Basman, Craig","Kliger, Chad A","Pirelli, Luigi","Scheinerman, S Jacob","32301976"],"journal":"Eur J Cardiothorac Surg","authors":["Basman, Craig","Kliger, Chad A","Pirelli, Luigi","Scheinerman, S Jacob"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301976","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1093/ejcts/ezaa152","keywords":["aortic stenosis","covid-19","elective surgery","surgical aortic valve replacement","transcatheter aortic valve replacement"],"topics":["Prevention"],"weight":1,"_version_":1666138494903255041,"score":235.5851},{"pmid":32498556,"title":"Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.","text":["Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.","The COVID-19 pandemic continues to significantly impact the treatment of people living with aortic stenosis, and access to transcatheter aortic valve implantation. Transcatheter aortic valve implantation (TAVI) programmes require unique coordinated processes that are currently experiencing multiple disruptions and are guided by rapidly evolving protocols. We present a series of recommendations for TAVI programmes to adapt to the new demands, based on recent evidence and the international expertise of nurse leaders and collaborators in this field. Although recommended in most guidelines, the uptake of the role of the TAVI programme nurse is uneven across international regions. COVID-19 is further highlighting why a nurse-led central point of coordination and communication is a vital asset for patients and programmes. We propose an alternative streamlined evaluation pathway to minimize patients' pre-procedure exposure to the hospital environment while ensuring appropriate treatment decision and shared decision-making. The competing demands created by COVID-19 require vigilant wait list management, with risk stratification, telephone surveillance and optimized triage and prioritization. A minimalist approach with close scrutiny of all parts of the procedure has become an imperative to avoid any complications and ensure patients' accelerated recovery. Lastly, we outline a nurse-led protocol of rapid mobilization and reconditioning as an effective strategy to facilitate safe next-day discharge home. As the pandemic abates, TAVI programmes must facilitate access to care without compromising patient safety, enable hospitals to manage the competing demands created by COVID-19 and establish new processes to support patients living with valvular heart disease.","Eur J Cardiovasc Nurs","Lauck, Sandra","Forman, Jacqueline","Borregaard, Britt","Sathananthan, Janarthanan","Achtem, Leslie","McCalmont, Gemma","Muir, Douglas","Hawkey, Marian C","Smith, Amanda","Hojberg Kirk, Bettina","Wood, David A","Webb, John G","32498556"],"abstract":["The COVID-19 pandemic continues to significantly impact the treatment of people living with aortic stenosis, and access to transcatheter aortic valve implantation. Transcatheter aortic valve implantation (TAVI) programmes require unique coordinated processes that are currently experiencing multiple disruptions and are guided by rapidly evolving protocols. We present a series of recommendations for TAVI programmes to adapt to the new demands, based on recent evidence and the international expertise of nurse leaders and collaborators in this field. Although recommended in most guidelines, the uptake of the role of the TAVI programme nurse is uneven across international regions. COVID-19 is further highlighting why a nurse-led central point of coordination and communication is a vital asset for patients and programmes. We propose an alternative streamlined evaluation pathway to minimize patients' pre-procedure exposure to the hospital environment while ensuring appropriate treatment decision and shared decision-making. The competing demands created by COVID-19 require vigilant wait list management, with risk stratification, telephone surveillance and optimized triage and prioritization. A minimalist approach with close scrutiny of all parts of the procedure has become an imperative to avoid any complications and ensure patients' accelerated recovery. Lastly, we outline a nurse-led protocol of rapid mobilization and reconditioning as an effective strategy to facilitate safe next-day discharge home. As the pandemic abates, TAVI programmes must facilitate access to care without compromising patient safety, enable hospitals to manage the competing demands created by COVID-19 and establish new processes to support patients living with valvular heart disease."],"journal":"Eur J Cardiovasc Nurs","authors":["Lauck, Sandra","Forman, Jacqueline","Borregaard, Britt","Sathananthan, Janarthanan","Achtem, Leslie","McCalmont, Gemma","Muir, Douglas","Hawkey, Marian C","Smith, Amanda","Hojberg Kirk, Bettina","Wood, David A","Webb, John G"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32498556","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1474515120934057","keywords":["covid-19","transcatheter aortic valve implantation","clinical pathway","multidisciplinary team"],"topics":["Prevention"],"weight":1,"_version_":1668804508929490944,"score":121.33861},{"pmid":32473912,"title":"Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","text":["Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.","Cardiovasc Revasc Med","Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S","32473912"],"abstract":["Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up."],"journal":"Cardiovasc Revasc Med","authors":["Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32473912","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.carrev.2020.05.030","keywords":["covid-19","cardiogenic shock","mitraclip","mitral regurgitation"],"topics":["Prevention"],"weight":1,"_version_":1668341932724584448,"score":73.60287},{"pmid":32445276,"title":"Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.","text":["Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.","The novel coronavirus, now termed SARS-CoV-2, has caused a significant global impact in the space of 4 months. Almost all elective cardiac surgical operations have been postponed with only urgent and emergency operations being considered in order to maximise resource utilisation. We present a case of a 69-year old lady with an infected prosthetic aortic valve for consideration of urgent inpatient surgery. Despite being asymptomatic and testing negative initially for COVID-19 RT-PCR swab, further investigations with CT revealed suspicious findings. She subsequently tested positive on a repeat swab and unfortunately deteriorated rapidly with complications including gastro-intestinal and intracerebral haemorrhage.","J Card Surg","Hussain, Azhar","Roberts, Neil","Oo, Aung","32445276"],"abstract":["The novel coronavirus, now termed SARS-CoV-2, has caused a significant global impact in the space of 4 months. Almost all elective cardiac surgical operations have been postponed with only urgent and emergency operations being considered in order to maximise resource utilisation. We present a case of a 69-year old lady with an infected prosthetic aortic valve for consideration of urgent inpatient surgery. Despite being asymptomatic and testing negative initially for COVID-19 RT-PCR swab, further investigations with CT revealed suspicious findings. She subsequently tested positive on a repeat swab and unfortunately deteriorated rapidly with complications including gastro-intestinal and intracerebral haemorrhage."],"journal":"J Card Surg","authors":["Hussain, Azhar","Roberts, Neil","Oo, Aung"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445276","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jocs.14643","keywords":["covid-19","cardiac surgery","endocarditis"],"topics":["Case Report"],"weight":1,"_version_":1667600475807023105,"score":72.191025},{"pmid":32484159,"title":"Managing Severe Aortic Stenosis in the COVID-19 Era.","text":["Managing Severe Aortic Stenosis in the COVID-19 Era.","The novel coronavirus-19 (COVID-19) pandemic has created uncertainty in the management of patients with severe aortic stenosis (AS). This population experiences high mortality from delays in treatment of valve disease but is largely overlapping with the population of highest mortality from COVID-19. We present strategies for managing patients with severe AS in the COVID-era. We suggest transitions to virtual assessments and consultation, careful pruning and planning of necessary testing, as well as fewer and shorter hospital admissions. These strategies center on minimizing patient exposure to COVID-19 and expenditure of human and health-care resources without significant sacrifice to patient outcomes during this public health emergency. Areas of innovation to improve our care during this time include increased use of wearable and remote devices to assess patient performance and vital signs, devices for facile cardiac assessment, and widespread use of clinical protocols for expedient discharge with virtual physical therapy and cardiac rehabilitation options.","JACC Cardiovasc Interv","Tanguturi, Varsha K","Lindman, Brian R","Pibarot, Philippe","Passeri, Jonathan J","Kapadia, Samir","Mack, Michael J","Inglessis, Ignacio","Langer, Nathan B","Sundt, Thoralf M","Hung, Judy","Elmariah, Sammy","32484159"],"abstract":["The novel coronavirus-19 (COVID-19) pandemic has created uncertainty in the management of patients with severe aortic stenosis (AS). This population experiences high mortality from delays in treatment of valve disease but is largely overlapping with the population of highest mortality from COVID-19. We present strategies for managing patients with severe AS in the COVID-era. We suggest transitions to virtual assessments and consultation, careful pruning and planning of necessary testing, as well as fewer and shorter hospital admissions. These strategies center on minimizing patient exposure to COVID-19 and expenditure of human and health-care resources without significant sacrifice to patient outcomes during this public health emergency. Areas of innovation to improve our care during this time include increased use of wearable and remote devices to assess patient performance and vital signs, devices for facile cardiac assessment, and widespread use of clinical protocols for expedient discharge with virtual physical therapy and cardiac rehabilitation options."],"journal":"JACC Cardiovasc Interv","authors":["Tanguturi, Varsha K","Lindman, Brian R","Pibarot, Philippe","Passeri, Jonathan J","Kapadia, Samir","Mack, Michael J","Inglessis, Ignacio","Langer, Nathan B","Sundt, Thoralf M","Hung, Judy","Elmariah, Sammy"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484159","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jcin.2020.05.045","topics":["Prevention"],"weight":1,"_version_":1668532114809683968,"score":47.033035}]}